1) Nimodipine
尼莫地平
1.
Preparation and Determination of Physical Properties of Nimodipine Emulsion Injection;
尼莫地平注射乳剂制备方法与物理性质的测定
2.
Preparation of Nimodipine gelatin microspheres and study of its characteristics;
尼莫地平明胶微球的制备及其性质研究
3.
Preparation of proliposome nimodipine and quality evaluation;
尼莫地平前体脂质体的制备及其质量评价
2) nimodipin
尼莫地平
1.
Effect of nimodipin on expression of PSD-95 in hippocampus of epileptic rats;
尼莫地平对癫痫大鼠海马突触后致密物95表达的影响
2.
Effects of Nimodipin and Ketamine on Cerebral Blood Flow and Metabolism in Rabbits with Cerebral Ischemic-Reperfusion;
尼莫地平和氯胺酮对缺血再灌注兔脑血流及代谢的影响
3.
Effection of Ligustrazine and Nimodipine on Expression of HSP70 in Brain Contusion Focus Perienchyma
川芎嗪、尼莫地平对脑挫伤灶周围区HSP70表达的影响
3) nimodiping
尼莫地平
1.
The protective effects of nimodiping in acute myocardial ischemia(AMI) injury in rats and its influence on apoptosis of cardiomyocytes;
尼莫地平对大鼠急性心肌缺血的保护作用及其对心肌细胞凋亡的影响
2.
Effective Observation of Nimodiping Combined with Hyperbaric Oxygen in Severe Injury of Brain;
尼莫地平联合高压氧治疗重型颅脑损伤的疗效观察
3.
Protective Effects of Nimodiping on Acute Myocardial Ischemia Injury in Rat and Its Influence on Apoptosis of Cardiomyocytes;
尼莫地平对大鼠急性心肌缺血损伤的保护作用及其对心肌细胞凋亡的影响
4) Nimodipine Tablets
尼莫地平片
1.
Kanjack Glucomannan Applyed in Preparing Nimodipine Tablets;
磨芋葡甘露聚糖在尼莫地平片制备中的应用
2.
Study on correlation between dissolution in vitro and absorption in vivo of nimodipine tablets;
尼莫地平片体外溶出度与体内吸收的相关性研究
3.
Objectives:The dissolution rates of nimodipine tablets from six different manufactories were investiga-ted with Fiber Optic In-situ Dissolution Monitor in four different mediums and rate of rotations.
目的:本文采用光纤药物溶出度实时测定仪对6个厂家的尼莫地平片分别在不同的四种介质中,不同转速下的溶出行为进行考察。
5) Nimodipine method
尼莫地平法
1.
Nimodipine method was adopted to observe the changes of cardinal sy.
方法：采用非盲法随机对照设计, 将60例患者随机分两组,并分别用自拟脂肝方(治疗组30例)和立普妥(对照组30例)治疗,采用尼莫地平法评价两组患者主要症状的变化,同时评价 B 超、血脂、肝功能变化；并记录与药物相关的不良反应。
6) Nimodipine eyedrop
尼莫地平滴眼液
补充资料：尼莫地平
分子式：C21H26N2O7
分子量：418.45
CAS号：66085-59-4
性质：结晶。熔点125℃。
制备方法：暂无
用途：一种新的钙拮抗剂。用于治疗脑血管疾病，如脑血管痉挛、缺血性脑座中早期血管性偏头痛，也用于突发性耳聋。
分子量：418.45
CAS号：66085-59-4
性质：结晶。熔点125℃。
制备方法：暂无
用途：一种新的钙拮抗剂。用于治疗脑血管疾病，如脑血管痉挛、缺血性脑座中早期血管性偏头痛，也用于突发性耳聋。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条